Chemokine receptor CCR5 and CXCR4 might influence virus replication during IBDV infection.
暂无分享,去创建一个
Yanhong Zhang | X. Kong | Yan Yu | C. Ou | Qiuxia Wang | Jinyou Ma | Xing-you Liu
[1] M. Dabrowska,et al. The expression of the chemokine receptor CCR5 in tick-borne encephalitis , 2016, Journal of Neuroinflammation.
[2] F. Bachelerie,et al. Symptomatic Improvement in Human Papillomavirus-Induced Epithelial Neoplasia by Specific Targeting of the CXCR4 Chemokine Receptor. , 2016, The Journal of investigative dermatology.
[3] A. Somasunderam,et al. Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial , 2016, PLoS pathogens.
[4] R. Rocha,et al. Dengue virus requires the CC‐chemokine receptor CCR5 for replication and infection development , 2015, Immunology.
[5] Hyun Kook Cho,et al. Hepatitis B virus X increases immune cell recruitment by induction of chemokine SDF‐1 , 2014, FEBS letters.
[6] C. Wu,et al. Chicken melanoma differentiation-associated gene 5 (MDA5) recognizes infectious bursal disease virus infection and triggers MDA5-related innate immunity , 2014, Archives of Virology.
[7] Nouri Neamati,et al. Small Molecule Inhibitors of CXCR4 , 2013, Theranostics.
[8] A. Kapatkin,et al. Long‐term administration of AMD3100, an antagonist of SDF‐1/CXCR4 signaling, alters fracture repair , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[9] N. Fujii,et al. Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4). , 2012, Organic & biomolecular chemistry.
[10] J. Murray,et al. Stochastic Model of In-Vivo X4 Emergence during HIV Infection: Implications for the CCR5 Inhibitor Maraviroc , 2012, PloS one.
[11] C. Ou,et al. Protocatechuic acid, a new active substance against the challenge of avian infectious bursal disease virus. , 2012, Poultry science.
[12] Yuan-zhi Yuan,et al. [Anti-angiogenesis effect of AMD3100 in oxygen-induced retinopathy mice]. , 2012, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.
[13] R. Selvaraj,et al. Chemokine receptor CCR7 and CXCR5 mRNA in chickens following inflammation or vaccination. , 2011, Poultry science.
[14] M. Khatri,et al. Differential modulation of cytokine, chemokine and Toll like receptor expression in chickens infected with classical and variant infectious bursal disease virus , 2011, Veterinary research.
[15] F. Sallusto,et al. Chemokines and leukocyte traffic , 2008, Nature Immunology.
[16] R. Jk,et al. CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions--review of the literature. , 2007 .
[17] B. Lambrecht,et al. Pivotal role of ChIFNγ in the pathogenesis and immunosuppression of infectious bursal disease , 2007 .
[18] John R. Young,et al. Transcriptional Profiling Reveals a Possible Role for the Timing of the Inflammatory Response in Determining Susceptibility to a Viral Infection , 2006, Journal of Virology.
[19] R. Wong,et al. Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4. , 2006, Biochemical pharmacology.
[20] P. Kaiser,et al. Infectious bursal disease virus: strains that differ in virulence differentially modulate the innate immune response to infection in the chicken bursa. , 2006, Viral immunology.
[21] K. Handberg,et al. Transcriptional profiles of chicken embryo cell cultures following infection with infectious bursal disease virus , 2006, Archives of Virology.
[22] Michael S Saag,et al. Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1 , 2005, Nature Medicine.
[23] S. Sze,et al. Genomic organization, annotation, and ligand-receptor inferences of chicken chemokines and chemokine receptor genes based on comparative genomics , 2005, BMC Genomics.
[24] D. Burt,et al. In-silico identification of chicken immune-related genes , 2004, Immunogenetics.
[25] J. Kwang,et al. Antigenic and Molecular Characterization of Recent Infectious Bursal Disease Virus Isolates in China , 2002, Virus Genes.
[26] A. Zlotnik,et al. Chemokines: agents for the immunotherapy of cancer? , 2002, Nature Reviews Immunology.
[27] S. Rautenschlein,et al. Role of intrabursal T cells in infectious bursal disease virus (IBDV) infection: T cells promote viral clearance but delay follicular recovery , 2002, Archives of Virology.
[28] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[29] Thomas Boehm,et al. Chemokines define distinct microenvironments in the developing thymus , 2000, European journal of immunology.
[30] In-Jeong Kim,et al. Characteristics of Bursal T Lymphocytes Induced by Infectious Bursal Disease Virus , 2000, Journal of Virology.